CBLL Stock Summary and Trading Ideas (Ceribell | NASDAQ:CBLL)

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Ceribell trades on the NASDAQ stock market under the symbol CBLL.

As of March 13, 2026, CBLL stock price climbed to $18.49 with 260,751 million shares trading.

CBLL has a beta of 0.66, meaning it tends to be less sensitive to market movements. CBLL has a correlation of 0.05 to the broad based SPY ETF.

CBLL has a market cap of $685.90 million. This is considered a Small Cap stock.

Last quarter Ceribell reported $25 million in Revenue and -$.36 earnings per share. This beat revenue expectation by $918,750 and exceeded earnings estimates by $.06.

The top ETF exchange traded funds that CBLL belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CBLL has underperformed the market in the last year with a return of -13.6%, while the SPY ETF gained +21.4%. In the last 3 month period, CBLL fell short of the market, returning -11.7%, while SPY returned -2.6%. However, in the most recent 2 weeks CBLL has outperformed the stock market by returning -1.0%, while SPY returned -3.5%.

CBLL support price is $17.84 and resistance is $18.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBLL shares will trade within this expected range on the day.